Skip to main content
ABL Diagnostics logo

ABL Diagnostics — Investor Relations & Filings

Ticker · ABLD ISIN · FR0000063034 LEI · 9695002UO0UHM0VKRH38 PA Manufacturing
Open in API
Filings indexed 114 across all filing types
Latest filing 2026-05-19 Regulatory Filings
Country FR France
Listing PA ABLD

About ABL Diagnostics

https://www.ablsa.com

ABL Diagnostics is a molecular diagnostics company that develops and commercializes solutions for the diagnosis and management of infectious diseases. The company's offerings include in-vitro diagnostic (IVD) medical devices, PCR-based assays such as the UltraGene product line, and integrated software for data analysis and laboratory automation. ABL Diagnostics also provides the Nadis® electronic medical record (EMR) system for clinical data management. The company specializes in genotyping and sequencing technologies, with a primary focus on monitoring drug resistance in viral infections like HIV and viral hepatitis.

Recent filings

Filing Released Lang Actions
Inside Information / Other news releases
Regulatory Filings Classification · 95% confidence The document is a press release by ABL Diagnostics announcing a broker research flash note and summarizing 2025 results. It is not the company’s actual Annual Report or financial statements (10-K/IR), nor a dividend notice or board change announcement. It merely announces the publication of a third-party research note (and references the annual report release). Therefore it falls into the general Regulatory Filings (RNS) category as a fallback for miscellaneous press releases.
2026-05-19 English
Informations privilégiées / Autres communiqués
Earnings Release Classification · 85% confidence The document is a press release summarizing the company’s full-year 2025 financial results (revenues, net profit, EBIT, cash flows, dividend proposal) and providing key highlights only, in line with an initial earnings announcement. It is not the full Annual Report itself but the earnings release of annual results. Therefore, it fits the “Earnings Release” category. FY 2025
2026-05-19 French
Inside Information / Other news releases
Notice of Dividend Amount Classification · 85% confidence The document is a company press release announcing its Board of Directors’ proposal for a dividend distribution for the financial year ended December 31, 2025, including the proposed per‐share amount, aggregate amount, record date (detachment), and payment date—all typical elements of a dividend notice. It does not contain full financial statements (so not an annual or interim report), nor does it relate to other categories such as M&A or management changes. Therefore, it is best classified under Notice of Dividend Amount (DIV).
2026-05-18 English
Informations privilégiées / Autres communiqués
Notice of Dividend Amount Classification · 90% confidence The document is a press release announcing the Board’s proposal for a specific dividend amount (€0.11 per share) for the 2025 fiscal year, with detachment and payment dates. It does not present full financial statements or detailed analysis, but specifically outlines the dividend distribution details for shareholder approval. This matches the definition of a Notice of Dividend Amount (DIV).
2026-05-18 French
Inside Information / News release on accounts, results
Earnings Release Classification · 87% confidence The document is a press release announcing ABL Diagnostics’ annual financial results for the fiscal year ended December 31, 2025. It provides key financial highlights (revenue, operating income, net income, cash flow), growth metrics, and business commentary. It is not the full annual report (10-K) or an attached detailed report; rather it is an initial earnings announcement summarizing performance. Therefore, it fits the Earnings Release category. FY 2025
2026-05-11 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 88% confidence The document is a press release announcing ABL Diagnostics’ annual financial results for the year ended December 31, 2025, with headline metrics (revenue, operational profit, net result) and highlights of growth, international expansion, and key partnerships. It does not include full audited financial statements or detailed report analysis typical of a 10-K/Annual Report. This style and content correspond to an Earnings Release. FY 2025
2026-05-11 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.